Literature DB >> 11267955

Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma.

D L Kwong1, W I Wei, A C Cheng, D T Choy, A T Lo, P M Wu, J S Sham.   

Abstract

BACKGROUND: Brachytherapy is useful for the reirradiation of nasopharyngeal carcinoma. In the current study, the long term treatment results of permanent radioactive gold(198) grain interstitial implantation in patients with persistent and recurrent nasopharyngeal carcinoma were reviewed.
METHODS: Gold grain implantation was performed under direct vision with a split palate approach to provide 60 grays (Gy) 0.5 cm away from the plane of implantation. Between August 1986 and May 1999, 106 patients were treated with gold grain implantation (45 patients for persistent disease, 53 patients for first recurrence, and 8 patients for second recurrence in the nasopharynx). All patients had histologically proven disease by biopsy before undergoing implantation.
RESULTS: Patients with persistent disease and those with first recurrence did well with the gold grain implantation. The 5-year local control rates for patients with persistent disease, first recurrence, and second recurrence in the nasopharynx were 87.2%, 62.7%, and 23.4%, respectively (P = 0.0004). The 5-year metastasis free survival rates were 68.1%, 60.3%, and 40%, respectively, for the 3 groups (P = 0.048). The overall survival rates at 5 years for the 3 groups were 79.1%, 53.6%, and 42.9%, respectively (P = 0.0047). Patients with computed tomography evidence of disease extension outside the nasopharynx had a lower local control rate compared with patients whose disease was confined to the nasopharynx (5-year local control rate of 52% vs. 72.3%; P = 0.031). The size of the lesion was not found to be an independent prognostic factor for local control after implantation. Multivariate analysis showed only an indication for implantation (persistent disease, first recurrence, and second recurrence) to be a significant prognostic factor for local control. Complications attributed to gold grain implantation included headache, palatal fistula, and mucosal radiation necrosis at the site of implantation, and were reported to occur in 28.3%, 18.9%, and 16%, respectively, of patients.
CONCLUSIONS: For selected patients with disease confined to the nasopharynx, gold grain implantation is an effective salvage treatment for persistent and recurrent nasopharyngeal carcinoma. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11267955

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma.

Authors:  Victor H F Lee; Dora L W Kwong; To-Wai Leung; Sherry C Y Ng; Ka-On Lam; Chi-Chung Tong; Chun-Kin Sze
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-13       Impact factor: 2.503

2.  Current management strategy of nasopharyngeal carcinoma.

Authors:  William I Wei; Dora L W Kwong
Journal:  Clin Exp Otorhinolaryngol       Date:  2010-03-30       Impact factor: 3.372

Review 3.  Current treatment options for recurrent nasopharyngeal cancer.

Authors:  Carlos Suárez; Juan P Rodrigo; Alessandra Rinaldo; Johannes A Langendijk; Ashok R Shaha; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-24       Impact factor: 2.503

Review 4.  Cancer of the nasopharynx: functional surgical salvage.

Authors:  William Ignace Wei
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

5.  Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer.

Authors:  Falk Roeder; Felix Zwicker; Ladan Saleh-Ebrahimi; Carmen Timke; Christian Thieke; Marc Bischof; Juergen Debus; Peter E Huber
Journal:  Radiat Oncol       Date:  2011-03-01       Impact factor: 3.481

6.  Diagnosis of post-radiotherapy local failures in nasopharyngeal carcinoma: a prospective institutional study.

Authors:  Puneet Kumar Bagri; Mukesh Kumar Singhal; Daleep Singh; Akhil Kapoor; Shankar Lal Jakhar; Neeti Sharma; Surender Beniwal; Harvindra Singh Kumar; Ajay Sharma; Megh Raj Bardia
Journal:  Iran J Cancer Prev       Date:  2014

7.  Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy.

Authors:  T Finazzi; T Rordorf; K Ikenberg; G F Huber; M Guckenberger; H I Garcia Schueler
Journal:  BMC Cancer       Date:  2018-04-06       Impact factor: 4.430

Review 8.  Photodynamic therapy in the therapy for recurrent/persistent nasopharyngeal cancer.

Authors:  Maarten A M Wildeman; Heike J Nyst; Baris Karakullukcu; Bing I Tan
Journal:  Head Neck Oncol       Date:  2009-12-17

Review 9.  Current treatment options for local residual nasopharyngeal carcinoma.

Authors:  S D Stoker; J N A van Diessen; J P de Boer; B Karakullukcu; C R Leemans; I B Tan
Journal:  Curr Treat Options Oncol       Date:  2013-12

10.  Magnetic Resonance Imaging-Detected Tumor Residue after Intensity-Modulated Radiation Therapy and its Association with Post-Radiation Plasma Epstein-Barr Virus Deoxyribonucleic Acid in Nasopharyngeal Carcinoma.

Authors:  Jia-Wei Lv; Guan-Qun Zhou; Jia-Xiang Li; Ling-Long Tang; Yan-Ping Mao; Ai-Hua Lin; Jun Ma; Ying Sun
Journal:  J Cancer       Date:  2017-03-07       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.